137 related articles for article (PubMed ID: 33799723)
1. The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular Carcinoma.
Caviglia GP; Abate ML; Rolle E; Carucci P; Armandi A; Rosso C; Olivero A; Ribaldone DG; Tandoi F; Saracco GM; Ciancio A; Bugianesi E; Gaia S
Biology (Basel); 2021 Mar; 10(3):. PubMed ID: 33799723
[TBL] [Abstract][Full Text] [Related]
2. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.
Cabibbo G; Petta S; Barbara M; Attardo S; Bucci L; Farinati F; Giannini EG; Negrini G; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Virdone R; Marra F; Mega A; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Colecchia A; Persico M; Craxì A; Trevisani F; Cammà C;
J Hepatol; 2017 Jul; 67(1):65-71. PubMed ID: 28192185
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
[TBL] [Abstract][Full Text] [Related]
4. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
Gómez-Rodríguez R; Romero-Gutiérrez M; Artaza-Varasa T; González-Frutos C; Ciampi-Dopazo JJ; de-la-Cruz-Pérez G; Sánchez-Ruano JJ
Rev Esp Enferm Dig; 2012 Jun; 104(6):298-304. PubMed ID: 22738699
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma.
Caviglia GP; Ciruolo M; Olivero A; Carucci P; Rolle E; Rosso C; Abate ML; Risso A; Ribaldone DG; Tandoi F; Saracco GM; Bugianesi E; Gaia S
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32998218
[TBL] [Abstract][Full Text] [Related]
6. Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area.
Lee JH; Kim HY; Kim YJ; Yoon JH; Chung JW; Lee HS
J Gastroenterol Hepatol; 2015 Apr; 30(4):696-705. PubMed ID: 25250761
[TBL] [Abstract][Full Text] [Related]
7. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients.
Merchante N; Rodríguez-Fernández M; Figueruela B; Rodríguez-Arrondo F; Revollo B; Ibarra S; Téllez F; Merino E; Montero-Alonso M; Galindo MJ; Rivero-Juárez A; Santos IL; Delgado-Fernández M; García-Deltoro M; Vera-Méndez FJ; García MA; Aguirrebengoa K; Portu J; Ríos-Villegas MJ; Villalobos M; Alemán-Valls MR; Mínguez C; Galera C; Macías J; Pineda JA;
AIDS; 2020 Aug; 34(10):1497-1507. PubMed ID: 32675563
[TBL] [Abstract][Full Text] [Related]
8. Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Bucci L; Garuti F; Camelli V; Lenzi B; Farinati F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Maida M; Felder M; Morisco F; Gasbarrini A; Gemini S; Foschi FG; Missale G; Masotto A; Affronti A; Bernardi M; Trevisani F; ;
Aliment Pharmacol Ther; 2016 Feb; 43(3):385-99. PubMed ID: 26662476
[TBL] [Abstract][Full Text] [Related]
9. Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma.
Nicolosi A; Gaia S; Risso A; Rosso C; Rolle E; Abate ML; Olivero A; Armandi A; Ribaldone DG; Carucci P; Fagoonee S; Pellicano R; Saracco GM; Bugianesi E; Caviglia GP
Minerva Gastroenterol (Torino); 2022 Dec; 68(4):378-386. PubMed ID: 36222678
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
11. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.
Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park MS; Kim EH; Seong J; Lee DY; Han KH
Liver Int; 2012 Aug; 32(7):1120-7. PubMed ID: 22524688
[TBL] [Abstract][Full Text] [Related]
12. Human Epidermal Growth Factor Receptor 2 (HER2) Expression by Immunohistochemistry and Its Clinical Significance in Hepatocellular Carcinoma: A Single-Center Analysis.
Magalhães D; Dos Santos J; Frutuoso A; Mesquita A
Cureus; 2023 Feb; 15(2):e34724. PubMed ID: 36909127
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF
Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946
[TBL] [Abstract][Full Text] [Related]
14. Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
Tsilimigras DI; Bagante F; Sahara K; Moris D; Hyer JM; Wu L; Ratti F; Marques HP; Soubrane O; Paredes AZ; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2019 Oct; 26(11):3693-3700. PubMed ID: 31267302
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble Toll-like receptor 4 and the risk of hepatocellular carcinoma in hepatitis C virus patients.
Elkammah M; Gowily A; Okda T; Houssen M
Contemp Oncol (Pozn); 2020; 24(4):216-220. PubMed ID: 33531868
[TBL] [Abstract][Full Text] [Related]
16. Validation and ranking of seven staging systems of hepatocellular carcinoma.
Chen ZH; Hong YF; Lin J; Li X; Wu DH; Wen JY; Chen J; Ruan DY; Lin Q; Dong M; Wei L; Wang TT; Lin ZX; Ma XK; Wu XY; Xu R
Oncol Lett; 2017 Jul; 14(1):705-714. PubMed ID: 28693224
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.
Giannini E; Risso D; Botta F; Romagnoli P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Testa R
J Intern Med; 2004 Mar; 255(3):399-408. PubMed ID: 14871465
[TBL] [Abstract][Full Text] [Related]
18. Secreted ERBB3 isoforms are serum markers for early hepatoma in patients with chronic hepatitis and cirrhosis.
Hsieh SY; He JR; Yu MC; Lee WC; Chen TC; Lo SJ; Bera R; Sung CM; Chiu CT
J Proteome Res; 2011 Oct; 10(10):4715-24. PubMed ID: 21877752
[TBL] [Abstract][Full Text] [Related]
19. Validation of The Hong Kong Liver Cancer Staging System in Patients with Hepatocellular Carcinoma after Curative Intent Treatment.
Chuncharunee A; Siramolpiwat S
Asian Pac J Cancer Prev; 2017 Jun; 18(6):1697-1701. PubMed ID: 28670891
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of untreated hepatocellular carcinoma.
Giannini EG; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Benvegnù L; Caturelli E; Zoli M; Borzio F; Chiaramonte M; Trevisani F;
Hepatology; 2015 Jan; 61(1):184-90. PubMed ID: 25234419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
